Imagine the heart-wrenching struggle of a new mother discovering she's HIV-positive right after giving birth, only to face a wall of fear and shame that could silence her forever. That's the gripping reality unfolding in Papua New Guinea, where the HIV epidemic is spiraling out of control amidst deep-rooted stigma and sudden cuts to vital international aid. But here's where it gets controversial: are these funding decisions from powerful nations like the US really just collateral damage in global politics, or a deliberate blow to the most vulnerable? And this is the part most people miss—the underlying factors fueling this crisis could be hiding in plain sight, waiting for bold action to change everything.
Let's dive into the story of Nancy Karipa, a brave woman from East Sepik in northern Papua New Guinea, who turned her diagnosis into a beacon of hope. Back in 1999, after years of battling unspecified illnesses and welcoming her first child, Nancy received the life-altering news that she was HIV-positive. 'It felt like a major turning point,' she recalls in a friendly chat at an AIDS awareness event in the capital, Port Moresby, last December. 'I was terrified of rejection, but I decided to take charge.' Thanks to prompt treatment for both her and her baby, her child is now thriving healthily. Nancy, now in her 50s, is a rare voice in a country where stigma around HIV runs deep—yet her courage underscores why sharing personal stories has never been more crucial. This year, Papua New Guinea officially labeled HIV a 'national crisis,' a step that's both urgent and overdue.
According to UNAIDS, the United Nations agency dedicated to combating HIV/AIDS worldwide, the epidemic in Papua New Guinea stands out as one of the fastest-growing in the Asia-Pacific region, alongside places like Fiji and the Philippines. Picture this: new infections have doubled since 2010, and shockingly, only about 59% of those living with the virus even realize they have it. What's particularly alarming is the spike in cases among women and children, highlighting vulnerabilities that demand immediate attention. Manoela Manova, UNAIDS's country director for Papua New Guinea, puts it starkly: 'The rate of mother-to-child transmission here is among the highest in the world.' For beginners wondering what that means, mother-to-child transmission occurs when an HIV-positive mother passes the virus to her baby during pregnancy, childbirth, or breastfeeding. Without proper prevention, like antiretroviral therapy (ART)—medications that suppress the virus and make transmission unlikely—this can happen in up to 45% of cases globally, but in Papua New Guinea, it's tragically higher.
The situation has worsened due to significant disruptions in funding for HIV support and prevention. Earlier this year, the Trump administration's suspension of US foreign aid—a move tied to broader geopolitical shifts—has crippled hundreds of clinics across the nation. On top of that, sharp reductions in global funding for UNAIDS programs are causing widespread worry among health experts, and there's growing pressure on the Papua New Guinean government to step up. Manova notes that HIV awareness has dwindled over time, leading to a dangerous illusion: 'It's as if the epidemic doesn't even exist anymore.' This misconception lingers not just in the public eye but among politicians too, making it harder to rally support.
In a country home to around 10 million people, the crisis is amplified by multiple challenges, such as insufficient testing facilities and low public knowledge. UNAIDS reports that Papua New Guinea saw an estimated 11,000 new HIV cases in 2024, with nearly half of them affecting children and young adults under 25. Even more distressing, about 2,700 infants were infected that year, often because their mothers didn't know their own HIV status and missed out on essential antiretroviral therapy (ART), which is highly effective at preventing transmission. As Manova explains, 'Many people remain unaware of their status, and that's the crucial first step—knowing so you can start treatment.' Think of ART as a powerful shield: when taken consistently, it not only protects the mother's health but can reduce transmission risk to less than 1%.
The freeze on US aid has hit clinics especially hard. In response, the government declared HIV a national crisis in June and rolled out an emergency plan focused on ramping up testing, treatment, and community support. Ken Wai, the deputy secretary of health, emphasizes that while the government handles drug supplies, other vital services like outreach and support have heavily depended on US assistance. The aid, channeled through the United States Agency for International Development (USAID), was cut off in January, though some has been partially restored for specific initiatives. 'USAID supports organizations like FHI360, which aid in data management and lab coordination at our central public health facility,' Wai adds, illustrating how these partnerships keep the system running.
Wep Kanawi, chair of the national AIDS council, agrees that the government needs to do more. The council focuses on preventing transmission and ensuring treatment nationwide. While it doesn't receive direct USAID funding for medications, Papua New Guinea taps into global non-profit organizations that benefit from USAID contributions, which in turn bolster local programs, including staff salaries. Kanawi reveals that over 200 clinics—run by the government or churches and offering essential HIV services—lost funding after the US aid suspension. He stresses the need for about K45-K50 million (roughly US$10 million) annually to combat the epidemic effectively. 'Many of our centers are still operating, but they're scaling back operations,' he warns, painting a picture of strained resources.
One such example is Kaugere Clinic in Port Moresby, which provides HIV care alongside other health services. Social worker Rose Marai describes the fallout vividly: when the Trump administration halted aid, salaries at the clinic dried up, leaving them without a backup plan. 'We were instructed to shut down, impacting entire communities,' she says. Her monthly stipend for community awareness programs dropped from K1,000 (about US$235) to just K240, forcing her to volunteer for counseling services for HIV-positive patients, those with sexually transmitted infections (STIs), and couples dealing with gender-based violence. It's a testament to the resilience of local workers, but it also highlights the gaps left by funding cuts.
The US embassy in Papua New Guinea declined to comment on USAID or funding specifics, but in a statement, they reaffirmed commitment: 'We are dedicated to our partnership with Papua New Guinea, with robust programs in security, disaster readiness, and health.' Meanwhile, UNAIDS is grappling with what it calls a 'historic funding crisis' this year, stemming from US aid reductions and cuts from other donors. A December UNAIDS report warns that these abrupt changes and shortfalls are 'profoundly and lastingly affecting the health of millions,' though some HIV programs have seen funding resume. Fortunately, Papua New Guinea has been somewhat protected so far, thanks to Australia stepping in with extra support. In October, Australia boosted its annual HIV development funding to nearly A$10 million for the financial year, helping to sustain UNAIDS operations in the country for at least two more years, as Manova notes.
Yet, amid rising infection rates, concerns are mounting that this epidemic exposes the fragility of Papua New Guinea's health system and its overreliance on foreign aid. Foreign Minister Justin Tkatchenko urges a 'fallback strategy,' emphasizing self-sufficiency. 'Our long-term goal is to manage this ourselves. We can't keep depending on donor partners forever,' he says, sparking debate on whether nations should prioritize sovereignty in health crises.
But here's where it gets controversial: are US aid cuts, often linked to broader political agendas, unfairly punishing vulnerable communities in Papua New Guinea? Some argue it's a necessary fiscal shift, prioritizing domestic needs, while others see it as a moral failing that endangers lives. And this is the part most people miss—the stigma surrounding HIV, rooted in misconceptions and fear, might be the biggest barrier, one that even funding can't fully address without cultural change. What do you think? Should wealthy nations prioritize global health aid during economic pressures, or is it time for countries like Papua New Guinea to build stronger internal systems? Do you agree that stigma is the silent killer here, or is there another factor at play? Share your thoughts in the comments—let's discuss how we can turn the tide on this crisis!
Rebecca Bush contributed to this report.
